|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/341 | (2006.01) |
| A61K 31/341 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3407880 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17703579.7 |
| Date of filing the European patent application | 2017-01-24 | |
| (97) | Date of publication of the European application | 2018-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/014702 |
| Date | 2017-01-24 |
| (87) | Number | WO 2017/132127 |
| Date | 2017-08-03 |
| (30) | Number | Date | Country code |
| 201662287062 P | 2016-01-26 | US |
| (72) |
MISSLING, Christopher, U. , US
|
| (73) |
Anavex Life Sciences Corp. ,
51 West 52nd Street 7th Floor, New York, NY 10019,
US
|
| (54) | TREATMENT OF RETT SYNDROME WITH THE COMPOUND A2-73 |
| TREATMENT OF RETT SYNDROME WITH THE COMPOUND A2-73 |